Loading clinical trials...
Loading clinical trials...
Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder
Conditions
Interventions
Apixaban
Locations
27
United States
Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Children'S Hospital Of Orange County
Orange, California, United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Childrens National Medical Center
Washington D.C., District of Columbia, United States
Children's Healthcare Of Atlanta
Atlanta, Georgia, United States
Start Date
January 10, 2013
Primary Completion Date
June 30, 2020
Completion Date
June 30, 2020
Last Updated
March 22, 2021
NCT06189313
NCT07015905
NCT03728166
NCT06939803
NCT03636295
NCT07310693
Lead Sponsor
Bristol-Myers Squibb
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions